[go: up one dir, main page]

NO20006312D0 - Therapeutic mixtures of selective estrogen receptor modulators (SERM) and growth hormone secretion stimulant (GHS) for the treatment of musculoskeletal fragility - Google Patents

Therapeutic mixtures of selective estrogen receptor modulators (SERM) and growth hormone secretion stimulant (GHS) for the treatment of musculoskeletal fragility

Info

Publication number
NO20006312D0
NO20006312D0 NO20006312A NO20006312A NO20006312D0 NO 20006312 D0 NO20006312 D0 NO 20006312D0 NO 20006312 A NO20006312 A NO 20006312A NO 20006312 A NO20006312 A NO 20006312A NO 20006312 D0 NO20006312 D0 NO 20006312D0
Authority
NO
Norway
Prior art keywords
ghs
serm
treatment
growth hormone
estrogen receptor
Prior art date
Application number
NO20006312A
Other languages
Norwegian (no)
Other versions
NO20006312L (en
Inventor
Hua Zhu Ke
Lei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20006312D0 publication Critical patent/NO20006312D0/en
Publication of NO20006312L publication Critical patent/NO20006312L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20006312A 1998-06-16 2000-12-12 Therapeutic mixtures of selective estrogen receptor modulators (SERMs) and growth hormone secretion stimulants (GHS) for the treatment of musculoskeletal fragility NO20006312L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en) 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (2)

Publication Number Publication Date
NO20006312D0 true NO20006312D0 (en) 2000-12-12
NO20006312L NO20006312L (en) 2000-12-12

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006312A NO20006312L (en) 1998-06-16 2000-12-12 Therapeutic mixtures of selective estrogen receptor modulators (SERMs) and growth hormone secretion stimulants (GHS) for the treatment of musculoskeletal fragility

Country Status (30)

Country Link
EP (1) EP1087764A1 (en)
JP (1) JP2002518326A (en)
KR (1) KR20010052852A (en)
CN (1) CN1301160A (en)
AP (1) AP9901582A0 (en)
AR (1) AR018869A1 (en)
AU (1) AU4054799A (en)
BG (1) BG105041A (en)
BR (1) BR9911324A (en)
CA (1) CA2335134A1 (en)
CO (1) CO5070587A1 (en)
EA (1) EA200001186A1 (en)
GT (1) GT199900087A (en)
HN (1) HN1999000097A (en)
HR (1) HRP20000859A2 (en)
HU (1) HUP0102505A3 (en)
ID (1) ID27599A (en)
IL (1) IL138630A0 (en)
IS (1) IS5691A (en)
MA (1) MA26652A1 (en)
NO (1) NO20006312L (en)
OA (1) OA11505A (en)
PA (1) PA8475901A1 (en)
PE (1) PE20000646A1 (en)
PL (1) PL344981A1 (en)
SK (1) SK18912000A3 (en)
TN (1) TNSN99124A1 (en)
TR (1) TR200003544T2 (en)
WO (1) WO1999065486A1 (en)
ZA (1) ZA993975B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360103A1 (en) * 1999-02-08 2000-08-17 Robert Sladek Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
EP1156120B1 (en) 2000-05-08 2006-11-22 Pfizer Products Inc. Enzymatic resolution of selective estrogen receptor modulators
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
ES2604943T3 (en) 2007-02-09 2017-03-10 Ocera Therapeutics, Inc. Ghrelin receptor macrocyclic modulators and procedures for their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (en) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS

Also Published As

Publication number Publication date
SK18912000A3 (en) 2001-10-08
AR018869A1 (en) 2001-12-12
CO5070587A1 (en) 2001-08-28
BG105041A (en) 2001-08-31
AU4054799A (en) 2000-01-05
MA26652A1 (en) 2004-12-20
GT199900087A (en) 2000-12-07
TNSN99124A1 (en) 2005-11-10
PE20000646A1 (en) 2000-08-05
JP2002518326A (en) 2002-06-25
WO1999065486A1 (en) 1999-12-23
AP9901582A0 (en) 1999-06-30
PA8475901A1 (en) 2000-05-24
EA200001186A1 (en) 2001-06-25
KR20010052852A (en) 2001-06-25
CA2335134A1 (en) 1999-12-23
IS5691A (en) 2000-10-27
ID27599A (en) 2001-04-12
HUP0102505A2 (en) 2001-11-28
IL138630A0 (en) 2001-10-31
HRP20000859A2 (en) 2001-04-30
EP1087764A1 (en) 2001-04-04
NO20006312L (en) 2000-12-12
HN1999000097A (en) 1999-11-03
TR200003544T2 (en) 2001-04-20
BR9911324A (en) 2001-04-03
CN1301160A (en) 2001-06-27
PL344981A1 (en) 2001-11-19
OA11505A (en) 2004-05-07
ZA993975B (en) 2000-12-15
HUP0102505A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
DK0991372T3 (en) Apparatus for dermatological treatment
DE60138129D1 (en) APPARATUS FOR THE TREATMENT OF TEETH
AU6359898A (en) Apparatus for controlled thermal treatment of tissue
DK0985697T3 (en) Oxirane derivatives and process for their preparation
NO20004098D0 (en) Methods and preparations for the treatment of macrophage-mediated disorders
NO985360L (en) Method and apparatus for human killing of fish
DE69731515D1 (en) Device for the treatment of photosensitive material
IS4805A (en) Method of treatment and pharmaceutical composition
EE200100053A (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
NO20003070D0 (en) Substituted thiazolidine derivative, method of preparation and use thereof
NO20006312D0 (en) Therapeutic mixtures of selective estrogen receptor modulators (SERM) and growth hormone secretion stimulant (GHS) for the treatment of musculoskeletal fragility
DK0994706T3 (en) Preparations for oral administration of taxanes and their use
NO995034L (en) Dental implant system and method of manufacture thereof
DK1003383T3 (en) Taste-enhancing N-ethyl-p-menthan-3-carboxamide-containing compounds and process for their preparation and use
DK1131083T3 (en) Use of growth hormone releasing compounds and antagonists thereof for the treatment of tumors
DK573189A (en) PROCEDURE AND APPARATUS FOR TREATMENT OF WASTE MATERIAL
NO20011824D0 (en) Controlled release fertilizer mixtures and processes for their preparation
DK205890A (en) METHOD AND APPARATUS FOR DISTRIBUTING MASSAGE MATERIALS
NO20006381D0 (en) Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents
NO20021947D0 (en) Bio-borne matrices, method of preparation and use thereof
NO20010773D0 (en) Procedures for quality control of bristles and use of such bristles
DK1031565T3 (en) Novel crystals of depsipeptide derivative and process for their preparation
DK1042036T3 (en) Process and apparatus for waste treatment
DK0891703T3 (en) Apparatus for the preparation and distribution of feed for cattle
NO20022990D0 (en) Method and composition for the treatment of pain

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application